The putative attachment protein of the avian pneumovirus that causes turkey rhinotracheitis is, by analogy with mammalian pneumoviruses, expected to be the major antigenic determinant. We report the nucleotide sequence of the attachment (G) protein genes of five different continental European isolates and compare them with the previously published sequence of the G gene for the focal variant of a U.K. isolate. The nucleotide sequences and the predicted amino acid sequences indicate that there are at least two distinct subgroups, similar to the grouping described for human respiratory syncytial (RS) virus. The U.K. and French isolates form one group and the isolates from Spain, Italy and Hungary form a second. The two subgroups can be easily distinguished on the basis of restriction enzyme digestion of PCR-generated products representing the full-length gene. Within the subgroups the predicted G proteins were highly conserved (98"5 to 99"7 % amino acid identity) compared to the levels of identity of RS virus G proteins in the same subgroup (80 to 95 %). Between the avian pneumovirus subgroups described here there was an unexpected degree of divergence, the average amino acid identity between members of the two groups being only 38%. This compares with the 53% conservation seen between members of the RS virus subgroups A and B. Comparison of the predicted amino acid sequences showed that the G proteins of members of the two avian pneumovirus subgroups had similar structural features. All proteins had an amino-terminal membrane anchor and the positions of cysteine residues were highly conserved. The potential importance of the high level of variation between the two subgroups in terms of epidemiology of the disease is discussed.
Introduction
Turkey rhinotracheitis was first described in South Africa in 1978 (Buys et al., 1989) and subsequently several outbreaks followed in the early 1980s in continental Europe (Giraud et al., 1986a, b) , the virus appearing in the U.K. in 1985 (Anon., 1985; McDougall & Cook, 1986 ). An avian pneumovirus, referred to as turkey rhinotracheitis virus (TRTV), was isolated and identified as the primary agent of the disease (McDougall & Cook, 1986; Wilding et al., 1986; Cavanagh & Barrett, 1986; Collins & Gough, 1988; Ling & Pringle, 1988) . The virions are pleiomorphic, though mainly spherical, with sizes ranging from 70 to 600 nm and the nucleocapsid, containing the linear, non-segmented, negative-sense RNA genome, shows helical symmetry (Collins et al., 1986; Giraud et al., 1986b) .
The sequences reported here have been deposited with the GenBank database under accession numbers L34030 (strain 1556), L34031 (strain 2119), L34032 (syncytial variant of strain CULl4/1), L34033 (strain 6574) and L34034 (strain 872S).
TRTV causes an acute respiratory tract infection both in turkeys and in chickens with a sudden onset and rapid spread through flocks (Anon., 1985) . Clinical signs are often mild, but in the presence of secondary bacterial agents the disease can be very severe and often fatal. Infection with the virus alone results in mortality in approximately 3% of cases, but respiratory infection with consequent morbidity is seen in all infected birds. Frequent consequences of infection are weight loss in fattening turkeys and a drop in egg production in laying hens (Jones et al., 1988) . As TRTV causes a considerable economic loss several attempts have been made to develop a live attenuated vaccine (Cook et al., 1989a, b; Cook & Ellis, 1990; Williams et al., 1991; Buys & du Preez, 1980) . Preliminary data suggest that vaccination can protect flocks from TRTV infections to a certain extent (Buys et al., 1989; Box, 1989) . The molecular basis of the attenuation of the vaccine virus is not known.
The two major antigens of pneumoviruses are the F (fusion) and G (attachment) glycoproteins. The G protein is known to be the most variable protein in human respiratory syncytial (RS) virus, the prototype pneumovirus. For human RS virus two subgroups, A and B, have been described with only 53 % amino acid identity between, and 80 to 95 % identity within, these subgroups in the case of the G protein (Johnson et al., 1987) .
The G gene of a U.K. isolate of TRTV has been sequenced (Ling et al., 1992) . The sequence was obtained from the focal variant of the CVL 14/1 isolate provided by the Central Veterinary Laboratory. In the original CVL 14/1 isolate two antigenically identical variants were identified and plaque purified based on different (focal and syncytial) plaque phenotypes (Ling & Pringle, 1988) . The G gene and the predicted protein had several features in common with the RS virus G gene and protein.
Comparison of several European strains of TRTV by ELISA and virus neutralization suggested that although they are related there is some diversity between them (Cook et al., 1993) . Further data were obtained from seven different TRTV isolates from different European countries (Collins et al., 1993) . These isolates were antigenically related but could be separated into two distinct groups. The antigenic relatedness detected in these assays may be due to highly conserved internal components, but there are greater differences between other viral proteins (Collins et al., 1993) . We have extended these data by determining the nucleotide sequences of the G genes of five different TRTV strains isolated in different European countries at different times, of which four are the same isolates examined by Collins et al. (1993) . Comparison of these with the previously published G gene sequences indicates considerable amino acid sequence variation in the TRTV attachment protein.
Methods
Virus strains. All TRTV strains were provided by the Central Veterinary Laboratory (Weybridge, U.K.). The focal variant of the CVL 14/1 isolate, which has been characterized by our laboratory, was used as a positive control. The other U.K. isolate used in the present work was the syncytial variant of the CVL 14/1 isolate (Ling & Pringle, 1988) . The non-U.K, isolates were strain 1556 isolated in France, 2119 from Italy, 657/4 from Hungary and 872S from Spain. All strains were grown in BS-C-1 cells in the presence of GMEM (Eagle's medium, Glasgow modification) supplemented with 2 % fetal calf serum at 37 °C. Each strain was grown once in BS-C-1 cells for a single pass to provide a virus stock, and this stock was passaged once more to provide RNA or viral proteins for the analyses described below. The passage history of the strains has been described previously (Ling & Pringle, 1988; Collins et al., 1993) .
cDNA and polymerase chain reaction (PCR). Total cytoplasmic RNA was harvested from 75 cm 2 flasks of virus-infected and mock-infected BS-C-1 cells using the method described by Ling & Pringle (1988) . Single-stranded cDNA was synthesized using oligo(dT) as a primer with AMV reverse transcriptase (Life Sciences) at 42 °C for 90 rain. An aliquot of cDNA was used in a PCR to amplify the full-length or required fragment of the G gene. For all strains oligonucleotides designated TRTG3 (GGGATCCCGGGACAAGTATCTCTATGG19), oli(dT) (GGCCCGGGAAGCTTTTTTTTTTTTTTTAal~3) and TRTG6 (s72GCCGGGTTGGTCTTCTGGGGss3) were used. Sequence differences between the strains required specific oligonucleotides to amplify certain portions of the gene. For focal, syncytial and 1556 strains oligonucleotide TRTG5 (CAAGATCTTTAGTTAACTAGTGCACA~lr6 ) was used. For 2119, 657/4 and 872S strains oligonucleotides TRTG10 (493GCACTTTGTCTTCCCATGGGG513), TRTG11 (746CAGGCCCTCGCAAAGAGGTCCTnr), TRTG12 (~2aCAGTCGCCTGTAATCTTCTAGGG~98), TRTG14 (~08GTGG-ACACTTATTGGGCGG228) and TRTGI5 (886CCCACAGCACA-GCAACTCCG905) were used. The figures refer to the nucleotide position to which the terminal nucleotides of the primers anneal in the G gene sequence of the different strains. Amplification took place in 30 cycles of denaturation at 94 °C for 45 s, annealing at 55 °C for 45 s and extension at 74 °C for 45 to 90 s, depending on the size of the required fragment. PCR products were either sequenced directly or cloned into pBluescript or MI3 (Stratagene) prior to sequencing.
Restriction analys&. PCR products representing the full length of the G gene were purified from agarose gels and digested with restriction enzymes as recommended by the manufacturers.
Cloning and sequencing. Full-length PCR products were digested with appropriate restriction enzymes and the fragments were end-filled with T4 DNA polymerase prior to cloning into Smal-digested pBluescript or M 13 mp 19. PCR products representing discrete portions of the G genes were end-filled and cloned as above. Both plasmid pBluescript-and M13-derived clones were sequenced using chain termination sequencing with Sequenase version 2.0 kit (USB) with the universal and reverse primers provided in the kit. Some pBluescript clones were sequenced using the A Taq Cycle Sequencing system (USB) with primers provided in the kit. To ensure accuracy, at least two independent clones containing each fragment were each sequenced twice. Alternatively, three or more independent clones were sequenced once. If it proved difficult to obtain clones representing certain fragments, data were obtained by direct sequencing of at least two independent PCR products. PCR products were sequenced using dsDNA cycle sequencing (BRL), A Taq cycle sequencing (USB) or Taq DyeDeoxy terminator cycle sequencing (Applied Biosystems) with terminal or internal primers.
In the case of the syncytial and 1556 strains PCR products were generated using oligonucleotides TRTG3 and TRTG2 (502CCACA-CTTGAAAGATCTACCC48z) and cloned into pBluescript and subsequently into MI3 mpl9. Two clones were obtained for each strain and these were sequenced with universal (-40) and reverse primers, twice each. These clones covered the first 500 bp of the G genes. To complete the sequence data of this area TRTG3 ~TRTG6 PCR products of both strains were digested with restriction endonuclease Rsal giving three fragments of 283 bp, 190 bp and 96 bp (data not shown). The 283 bp fragment, representing the G gene between nucleotide positions 97 and 380, was cloned into pBluescript. Two clones for each strain were sequenced twice. Additionally, independent PCR products were sequenced twice with primers TCS1 (3ACA-AGTATCTCTATGGGGTCC24 ) and TCS2 (162CATAGTTGAAC-AGTCAGTGTT188). Digestion of the full-length PCR product of these two strains with restriction endonuclease HinclI gave fragments with sizes of 733 bp, 231 bp, 223 bp and 6bp. The 733 bp fragment representing the G gene between nucleotide positions 454 to 1187 was cloned into pBluescript. At least two clones of each strain were sequenced, at least twice each, with universal and reverse primers. To complete the sequence data, a 470 bp fragment was produced by PCR, using primers TCS3 (~rlGCATGGCCTAGCCAAGACs88) and TCS4 (1043TGCTTTGTAATATTGGAGTTGT1022). Independent PCR pro- ducts were sequenced directly using TCS3 and TCS4 primers at least twice with each strain. In the case of strains 2119, 657/4 and 872S digestion of the fulllength PCR product with restriction enzyme HinclI gave fragments of 715 bp, 243 bp, 233 bp and 69 bp (data not shown). The 715 bp fragment, representing the G gene between positions 254 to 970, was cloned into pBluescript and a minimum of two clones each were sequenced with universal and reverse primers, at least three times. For strain 657/4 one clone of the 243 bp fragment was obtained in pBluescript and sequenced with universal and reverse primers. This represented the first 243 bp of the G gene.
Digestion of the full-length PCR product of strains 2119, 657/4, 872S with Rsal resulted in four fragments of 661 bp, 382 bp, 204 bp and 13 bp. In the case of strain 872S three clones of the 204 bp fragment representing the G gene between positions 382 to 586, three clones of the 661 bp fragment representing the G gene between positions 586 to 1247, and two clones of the 382bp fragment representing the first 382 bp of the G gene were obtained in pBluescript and each clone was sequenced with universal and reverse primers. For strains 2119 three, and for strain 657/4 two pBluescript clones of the RsaI 204 bp fragment were sequenced with universal and reverse primers. Overlapping PCR fragments were generated to complete the sequence with primers designed on the basis of the sequence data obtained from the cloned fragments of these strains (Table 1) . With all oligonucleotides at least two independent PCR products of strains 2119, 657/4 and 872S were sequenced directly, providing full-length sequence data for the G gene.
Results

PCR products
The results of all the different PCRs are summarized in Table 1 . The PCR product representing the full-length G gene was obtained using TRTG3 and oli(dT) oligonucleotides (Table 1) In any other possible combinations of the oligonucleotide primers, the PCR results showed that the different strains fell into one of two distinct groups (Table 1 ). The syncytial variant of the U.K. CVL 14/1 strain and the French (1556) isolate gave the same sized products as the previously sequenced focal variant of CVL 14/1 U.K. isolate. All the PCR primers designed previously for the focal strain annealed to these two strains and gave the predicted products. The other continental European strains, 2119 (Italian), 657/4 (Hungarian) and 872S (Spanish), gave different results. Only three of the original primers [TRTG3, TRTG6 and oli(dT)] produced amplified products with these strains. Oligonucleotide primers TRTG3 and TRTG6 generated two fragments of 750 bp and 400 bp compared to the 550 bp fragment from the focal strain (data not shown). In further cloning experiments only the 750 bp fragment of this PCR was used. All the other primers used for strains 2119, 657/4 and 872S were designed on the basis of sequence data derived from these strains and did not anneal to the focal variant of CVL 14/1 in PCRs. A summary of the results of these reactions is shown in Table 1 . These differences in the sizes of the PCR products suggested that there was considerable sequence variation, especially towards the 3' end, in the G mRNAs of the different strains.
Restriction digestions
Digestion of the PCR products representing the full length of the G genes of the different isolates with restriction enzymes supported the data obtained by PCRs. The digestion patterns clearly indicated that two distinct groups could be differentiated (Fig. 1) 
Cloning and sequencing
Discrete and overlapping fragments of the G genes were cloned into pBluescript and in some cases subcloned into M13. However, cloning some portions of the G genes and/or subcloning into M 13 was not successful, possibly due to toxicity of minimally expressed proteins. The sequences of the G genes and the amino acid sequences of their predicted proteins are shown in Figs 2 and 3. The levels of identity of the isolates, compared pairwise, are summarized in Table 2 .
The G genes of the syncytial and 1556 strains were almost identical to the G gene of the focal isolate. There was only one change in the nucleotide sequence of the G gene in the syncytial variant compared to the focal variant. This T ~ C nucleotide change at position 38 resulted in an amino acid change from valine to alanine in the G protein at amino acid position 8 in the syncytial strain. The nucleotide changes, their positions and the coding changes are shown in Fig. 2 .
There were 10 nucleotide base changes in the G gene of the 1556 strain compared to the focal strain and 11 compared to the syncytial strain. Five of these changes were silent point mutations while 5/6 appeared as an amino acid change in the G protein compared to the focal/syncytial G proteins.
The G genes of strains 2119,657/4 and 872S were 1260 bases long, 67 bases longer than the G gene of the focal strain. The G genes of these strains showed 56.6 to 57 % nucleotide sequence identity to the G gene of the tbcal strain. Between nucleotide positions 293 to 449 of the focal strain and 296 to 452 of strains 2119, 657/4 and 872S the nucleotide sequence was highly conserved with identity ranging between 82.05 to 82.68%. The G proteins of strains 2119, 657/4 and 872S contain 414 amino acids, 23 residues longer than the focal G protein.
Of the 414 residues 161 to 164 were conserved with 38'2 to 38"8 % identity between the G proteins of the focal strain and strains 2119, 657/4 and 872S (Table 2 ). The G genes of strains 2119, 657/4 and 872S were well conserved when compared to each other. There are five nucleotide and three amino acid changes in strain 2119 and four nucleotide and two amino acid changes in strain Fig. 2 . Complete nucleotide sequence of the G gene of the focal isolate of TRTV (Ling et al., 1992) as a representative of the subgroup A viruses aligned with the complete nucleotide sequence of the G gene of strain 2119 of TRTV as a representative of subgroup B viruses. The positions of nucleotide differences in the subgroup A, syncytial and 1556 strains, are shown above that of the focal strain and changes in the subgroup B, 657/4 and 872S strains are shown below that of strain 2119. Gaps introduced to optimize the alignment are indicated G). Nucleotides that are identical in the two viruses are indicated (*); sequence differences that result in a coding change with respect to the prototype virus of each subgroup are underlined. , and gaps to optimize the alignment (-) are indicated. The alignment was performed using the CLUSTAL program (Higgins & Sharp, 1988) . 872S when compared to strain 657/4. Strains 2119 and 872S have seven nucleotide and five amino acid changes compared to each other. The amino acid identity of these strains ranged between 98.8% and 99"3% (Table 2) . On the basis of the nucleotide sequence identities, strain 2119 seemed to be more similar to the focal strain, while on the basis of amino acid sequence identities the 872S strain proved to be more closely related.
Discussion
Comparisons of several European and South African TRTV isolates by ELISA and virus neutralization has shown that these isolates were antigenically clearly related but could be separated into two distinct groups (Cook et al., 1993; Collins et al., 1993) . We have extended this analysis by determining the nucleic acid sequences of the G genes of five different European strains, some of which were the same isolates used in previous studies. These data suggested that there were at least two subgroups in TRTV. We propose that these be named subgroup A, formed by the U.K. and French strains, and subgroup B formed by the other continental European (2119, 657/4 and 872S) strains, to be consistent with the pneumovirus nomenclature system established for RS virus. Analysis of total viral proteins of the six TRTV strains by Western blotting and radioimmunoprecipitation (data not shown) also indicated that the mobility of the P protein differed slightly, with the U.K. and French strains being distinguishable from the other continental European strains. This is similar to the situation with RS virus where the two subgroups, A and B, can be distinguished on the basis of the mobility of their P proteins (Gimenez et al., 1986) .
Restriction analysis of the PCR products representing the full-length G gene further emphasized the presence of two clearly distinguishable groups (Fig. 1) . Restriction enzyme digestion has been used to distinguish several lineages of RS virus , and this can be used as a rapid method to type clinical isolates.
The sequences of a number of G genes revealed that in the avian pneumovirus subgroup A the G gene was 1193 bases in length while in subgroup B it was 1260 bases (Fig. 2) . In RS virus a smaller size difference of the G genes (three nucleotides) has been reported between subgroups A and B (Johnson et al., 1987) . Within avian pneumovirus subgroup A the nucleotide sequence identity was 99.1 to 99.9 %, while in subgroup B it was 99-4 to 99'7 %, and the nucleotide sequence identity between the two subgroups ranged between 56"3 and 57%. The deduced amino acid sequence of the G proteins revealed significant similarities and differences amongst the members of the two subgroups. There was only approximately 38 % amino acid identity between subgroups A and B of TRTV. This is a very low level of identity between related proteins and is considerably lower than the 53% identity between the RS virus subgroups (Johnson et al., 1991) , suggesting that more antigenic variation exists between the two subgroups of TRTV than is seen between subgroups of RS virus. A major characteristic feature of the G proteins, the high proline, serine and threonine content, was conserved in the two subgroups of TRTV. G proteins of subgroup A contained 6.6% proline, 10% serine and 13-6% threonine residues, while subgroup B G proteins had 8.5 % proline, 11"8 % serine and 12'8 % threonine residues. Of 20 cysteine residues present in the G proteins of subgroup A viruses, 19 were conserved in the same relative positions in subgroup B. The cysteine residue at amino acid position 41 in the subgroup A G protein was replaced by a cysteine residue at position 50 in the subgroup B protein (Fig. 3) . Since cysteine residues can play a significant role in the molecular structure of the proteins, conservation of these residues may mean that despite the low level of amino acid identity between the two subgroups the structure of the G proteins is similar. Alignment of the predicted protein sequences of the subgroup A and B viruses showed that the N-termini were more conserved, with two highly conserved hydrophobic domains, than were the C-termini (Fig. 3) . The first conserved hydrophobic area was between amino acid positions 32 and 45, and this could function as a transmembrane region analogous to that of the RS virus G protein (Wertz et al., 1985) . The second highly conserved hydrophobic area in subgroup A was between positions 118 and 142, while in subgroup B it was between residues 119 and 143 (Fig. 3) . The second conserved hydrophobic area was followed by a variable domain between amino acid positions 143 and 309 in subgroup A and 142 and 331 in subgroup B. This region was mainly hydrophilic in subgroup A (with only a short hydrophobic area within), while in subgroup B it was entirely hydrophilic. The C termini of the G proteins of the two subgroups were conserved, unlike the situation in the RS virus G protein , and showed a gradual change from hydrophilic areas to hydrophobic towards the C termini.
The well conserved cysteine residues and the fact that the conserved areas are mainly hydrophobic suggested that although there is only a 38 % identity in the amino acid sequence between the two subgroups the conformation of the G proteins in the two subgroups may be similar. The first hydrophobic domain may function as a transmembrane region, while the second conserved hydrophobic region together with the conserved hydrophobic C terminus could be an inner structural part of the extramembrane region, exposing the variable hydrophilic region of the G protein to the surface.
The data presented here clearly show the existence of two distinct subgroups of avian pneumovirus. The unexpectedly high level of sequence diversity between the two subgroups raises questions about the potential impact of the variation on the epidemiology of TRTV infections. In particular, it will be of interest to investigate whether infection with a virus belonging to one subgroup confers any degree of resistance to challenge from a second infection with a member of the other subgroup. This may have significant consequences for the choice of possible candidate vaccine strains. Additionally, further work is required to establish the geographical distribution of the subgroups and to determine whether further subgroups are present.
